Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
375.40
0.00 (0.00%)
At close: Sep 25, 2025
36.11%
Market Cap 8.09B
Revenue (ttm) 438.99M
Net Income (ttm) -240.04M
Shares Out n/a
EPS (ttm) -10.91
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 8
Open 375.40
Previous Close 375.40
Day's Range 375.40 - 375.40
52-Week Range 237.50 - 381.90
Beta n/a
RSI 51.45
Earnings Date Oct 28, 2025

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.